Lipoma
14
4
5
8
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 37/100
0.0%
0 terminated out of 14 trials
100.0%
+13.4% vs benchmark
0%
0 trials in Phase 3/4
50%
4 of 8 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 8 completed trials
Clinical Trials (14)
Intralesional Ronkyla Plus Injection for the Treatment of Superficial Lipoma
Ultrasound-Guided Emulsification Therapy in the Clinical Treatment of Subcutaneous Lipomas
RFA for Superficial Lipomas
Radiological Diagnosis of Pediatric Neck Swellings
Lipomas Treated With Subcutaneous Injections of Cooled or Warmed Sodium Chloride
Optimizing the Timing for Facial Surgical Dressing Removal
Impact of Skin Type on Wonud Healing and Scarring Following Facial Skin Surgery
Evaluating the Efficacy and Safety of Embella (Deoxycholic Acid, Produced by Espad Pharmed Co.) Injection in the Management of Superficial Lipomas
Incisional Negative Pressure Wound Therapy for Resection of Soft Tissue Tumors
Double Blind Study to Evaluate the Efficacy of Collagenase Histolyticum in the Treatment of Lipoma
A Dose Escalation Study Using Collagenase Clostridium Histolyticum in the Treatment of Lipoma
Phase 2 Study for the Treatment of Superficial Lipomas
Association of Beta-2 Adrenergic Agonist and Corticosteroid Injection in the Treatment of Lipomas
Deoxycholic Acid Injection for the Treatment of Superficial Lipomas